60 Degrees Pharmaceuticals (SXTP) Return on Equity (2023 - 2025)
60 Degrees Pharmaceuticals (SXTP) has disclosed Return on Equity for 3 consecutive years, with 0.18% as the latest value for Q3 2025.
- On a quarterly basis, Return on Equity rose 93.0% to 0.18% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.18%, a 93.0% increase, with the full-year FY2024 number at 0.13%, down 22.0% from a year prior.
- Return on Equity was 0.18% for Q3 2025 at 60 Degrees Pharmaceuticals, down from 0.14% in the prior quarter.
- In the past five years, Return on Equity ranged from a high of 0.38% in Q3 2023 to a low of 1.11% in Q3 2024.
- A 3-year average of 0.07% and a median of 0.12% in 2024 define the central range for Return on Equity.
- Peak YoY movement for Return on Equity: crashed -149bps in 2024, then surged 93bps in 2025.
- 60 Degrees Pharmaceuticals' Return on Equity stood at 0.14% in 2023, then rose by 18bps to 0.12% in 2024, then crashed by -55bps to 0.18% in 2025.
- Per Business Quant, the three most recent readings for SXTP's Return on Equity are 0.18% (Q3 2025), 0.14% (Q2 2025), and 0.72% (Q1 2025).